This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Weight Gain and Antipsychotic Medication

George L. Blackburn, MD, PhD

Published: May 30, 2000

Article Abstract

Antipsychotic-treated patients, who tend to take combinations of psychotropic agents that maycause weight gain, are at special risk for the problems associated with being overweight or obese.Medical and psychiatric examinations should include periodic monitoring for weight change and anobesity assessment for weight-related medical illness. The assessment should involve evaluation ofbody mass index and waist circumference as well as medical history. Preventative strategies should beundertaken for patients who gain 5 lb (2.3 kg) or more within a 3-year period. A change in antipsychoticsmay be necessary for overweight patients who are unwilling or unable to lose weight. A treatmentplan for overweight or obese patients should include periodic monitoring and recommendationsfor changes in diet and physical activity. Support groups and adjunct medication may also be helpful.The patient should be reminded of the benefits of even modest weight loss.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...